Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities Tariq KewanMaximillian StahlAmer M. Zeidan ReviewPaper 18 April 2024
Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia Reema K. TawfiqJithma P. AbeykoonPrashant Kapoor ReviewPaper 27 March 2024
Update on T-Cell Lymphoma Epidemiology Jane J. ChenFranco Castillo TokumoriJia Ruan ReviewPaper 07 March 2024
Management of Patients with Early Myelofibrosis: A Discussion of Best Practices Prithviraj Bose ReviewPaper Open access 05 March 2024
Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Strategies to Optimize Success and New Directions Delphine ReaSofiane FodilJean-Michel Cayuela ReviewPaper 23 February 2024
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations Fatima WarsameDouglas A. Simonetto ReviewPaper 19 February 2024 Pages: 75 - 81
Frontline Therapy of CLL—Changing Treatment Paradigms Catherine C. Coombs ReviewPaper 10 February 2024 Pages: 65 - 74
Transplantation and Cellular Therapy for Older Adults—The MSK Approach Richard J. LinParastoo B. DahiSergio A. Giralt ReviewPaper 09 February 2024 Pages: 82 - 91
Pulmonary, Hepatic, and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Telomere Biology Disorders Kelly M. PenningtonDouglas SimonettoAbhishek A. Mangaonkar ReviewPaper 05 February 2024
How Do We Manage Chronic Lymphocytic Leukemia in India Parathan KarunakaranNidhi JainDeepesh P. Lad ReviewPaper 01 February 2024 Pages: 56 - 64
Treatment of Richter’s Transformation with Novel Therapies Amneet BajwaAlma HabibAdam S. Kittai ReviewPaper Open access 09 January 2024 Pages: 45 - 55
Diagnosis and Management of Pulmonary Manifestations of Telomere Biology Disorders Kathryn T. del ValleEva M. Carmona ReviewPaper Open access 30 December 2023
Adaptive and Maladaptive Clonal Hematopoiesis in Telomere Biology Disorders Terra LashoMrinal M. Patnaik ReviewPaper 14 December 2023 Pages: 35 - 44
Blinatumomab in Practice Jeffrey LantzNatalie PhamMichael Keng ReviewPaper 07 December 2023 Pages: 1 - 8
Novel Biomarkers and Molecular Targets in ALL Hong De SaJessica Leonard ReviewPaper 04 December 2023 Pages: 18 - 34
Unlocking the Potential of Artificial Intelligence in Acute Myeloid Leukemia and Myelodysplastic Syndromes Abdulrahman AlhajahjehAziz Nazha ReviewPaper 24 November 2023 Pages: 9 - 17
Experimental and Computational Approaches to Measure Telomere Length: Recent Advances and Future Directions Alejandro FerrerZachary D. StephensJean-Pierre A. Kocher ReviewPaper Open access 10 November 2023 Pages: 284 - 291
Measurable Residual Disease Monitoring in Lymphoma Brian CuzzoAndrew LipskyHua-Jay J. Cherng ReviewPaper 06 November 2023 Pages: 292 - 304
Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders Naoki OishiReham AhmedAndrew L. Feldman ReviewPaper 23 October 2023 Pages: 252 - 263
Genetic Counseling and Family Screening Recommendations in Patients with Telomere Biology Disorders Laura OngieHannah A. RajKatie Barrett Stevens ReviewPaper 03 October 2023 Pages: 273 - 283
NK Cell Therapeutics for Hematologic Malignancies: from Potential to Fruition Stephanie L. FetzkoLeander D. TimothyRobin Parihar ReviewPaper 26 September 2023 Pages: 264 - 272
An Update on the Management of Advanced Phase Chronic Myeloid Leukemia Nicholas J. ShortJayastu SenapatiElias Jabbour ReviewPaper 31 August 2023 Pages: 234 - 242
Central Nervous System Relapse in T and NK cell Lymphomas Eleanor P. TarantoStefan K. BartaRahul S. Bhansali ReviewPaper 25 August 2023 Pages: 243 - 251
EBV Reactivation and Lymphomagenesis: More Questions than Answers Maegan FordEvelyn OrlandoJennifer Effie Amengual ReviewPaper 11 August 2023 Pages: 226 - 233
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions Megan Sears-SmithThomas G. Knight ReviewPaper 25 July 2023 Pages: 158 - 166
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma Adam S. DuVallAustin WesevichRichard A. Larson ReviewPaper 25 July 2023 Pages: 217 - 225
Multiple Myeloma: Current Clinical Landscape and Compounding Costs Kelsey BeckTyler SandahlChelsee Jensen ReviewPaper 21 July 2023 Pages: 201 - 215
Response-Adapted Therapy for Newly Diagnosed Multiple Myeloma Winnie Z. Y. TeoIan Y. E. OngSanjay de Mel ReviewPaper 04 July 2023 Pages: 190 - 200
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative Diseases Andrea DuminucoElena TorreClaire Harrison ReviewPaper 03 July 2023 Pages: 176 - 189
Real-world Management of CML: Outcomes and Treatment Patterns Nicole HeldEhab L. Atallah ReviewPaper 03 July 2023 Pages: 167 - 175
Richter Transformation of Chronic Lymphocytic Leukemia—Are We Making Progress? Hadiyah Y. AudilSamuel R. KosydarSameer A. Parikh ReviewPaper 09 June 2023 Pages: 144 - 157
Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Oluwatobi OdetolaShuo Ma ReviewPaper 06 June 2023 Pages: 130 - 143
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations Ji YuanRong HeHassan B. Alkhateeb ReviewPaper Open access 01 June 2023 Pages: 121 - 129
GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation Roma V. RajputDanielle E. Arnold ReviewPaper 29 May 2023 Pages: 89 - 97
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer Tiziano BarbuiAntonello GavazziAlessandra Carobbio ReviewPaper 24 May 2023 Pages: 105 - 112
Pelabresib (CPI-0610): An Exciting Novel Drug for the Treatment of Myelofibrosis Guadalupe Ferreira GomesClaire Harrison ReviewPaper 17 May 2023 Pages: 113 - 120
A Pragmatic Approach to Managing Long-Term Adverse Effects in Chronic Myeloid Leukemia Treatment Josephine Anne LuceroJeffrey H. Lipton ReviewPaper 16 May 2023 Pages: 98 - 104
Therapeutic Targets in Myelodysplastic Neoplasms: Beyond Hypomethylating Agents Prateek PophaliSudhamsh Reddy DesaiAditi Shastri ReviewPaper 13 April 2023 Pages: 56 - 67
New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications Daniel E. LunaMichi M. Shinohara ReviewPaper 05 April 2023 Pages: 83 - 88
Managing Survivorship after Hematopoietic Cell Transplantation Nandita Khera ReviewPaper 30 March 2023 Pages: 75 - 82
Approach to the Treatment of Philadelphia Chromosome-Negative B-cell ALL in Older Adults: Is Age Becoming just a Number? Yuchen LiuVu H. Duong Acute Lymphocytic Leukemia (Fe Chaer and M Keng, Section Editors) 06 March 2023 Pages: 68 - 74
CML Outcomes and Care Delivery During the COVID-19 Pandemic in Low- and Middle-Income Countries Mika MatsuzakiAlicia AnnamalayJerald Radich Chronic Myeloid Leukemias (V. Oehler, Section Editor) 15 February 2023 Pages: 1 - 7
The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities Shaun David PattersonMhairi Copland Chronic Myeloid Leukemias (V Oehler, Section Editor) Open access 13 February 2023 Pages: 19 - 32
Family Planning and Pregnancy in Patients with Chronic Myeloid Leukemia Ellin Berman Chronic Myeloid Leukemias (V Oehler, Section Editor) 10 February 2023 Pages: 33 - 39
CAR-T Cell Therapy: the Efficacy and Toxicity Balance Karan L. ChohanElizabeth L. SieglerSaad S. Kenderian CART and immunotherapy (M Ruella and P Hanley, Section Editors) 10 February 2023 Pages: 9 - 18
Targeted Therapy for MPNs: Going Beyond JAK Inhibitors Evan C. ChenHannah JohnstonAnand Ashwin Patel Acute Myeloid Leukemias (U Borate, Section Editor) 27 January 2023 Pages: 41 - 55
The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma Arleigh McCurdyAlissa Visram Multiple Myeloma (Prashant Kapoor, Section Editor) 22 November 2022 Pages: 306 - 318
Molecular Pathogenesis of Myeloproliferative Neoplasms Benjamin RollesAnn Mullally Myeloproliferative Neoplasms (P Bose, Section Editor) 07 November 2022 Pages: 319 - 329
Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies Himachandana AtluriYoheved S. GersteinCourtney D. DiNardo Germline Predisposition to Myeloid Neoplasms (M Patnaik, Section Editor) 24 October 2022 Pages: 275 - 285
CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions Emilia ScalzulliIda CarmosinoMassimo Breccia Chronic Myeloid Leukemias (V Oehler, Section Editor) 20 October 2022 Pages: 198 - 205
